Genocea Biosciences reported $50.61M in Current Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Baxter International BAX:US $ 8167M 163M
Bluebird Bio BLUE:US $ 832.32M 71.2M
Cytokinetics CYTK:US $ 494.94M 130.71M
Cytori Therapeutics CYTX:US $ 22.1M 4.1M
Genocea Biosciences GNCA:US $ 50.61M 12.3M
Glaxosmithkline GSK:US $ 18254M 688M
Infinity Pharmaceuticals INFI:US $ 91.93M 7.75M
Mirati Therapeutics MRTX:US $ 1171.89M 106.2M
Moderna Inc MRNA:US 13.42B 2.46B
Novavax NVAX:US $ 2174.18M 180.81M
Prothena PRTA:US 607.53M 198.06M